INNOVENT BIOLOGICS INC earnings per share and revenue

1801 earnings per share for the last semiannual are -0.26 HKD whereas the estimation was -0.27 HKD which accounts for 4.00% surprise. Company revenue for the same period amounts to 4.25 B HKD despite the estimated figure of 4.07 B HKD. Estimated earnings per share for the next semiannual are -0.20 HKD, and revenue is expected to reach 5.15 B HKD. Also watch annual changes over time to get a bigger picture of 1801 earnings per share and revenue dynamics.